Insider · CIK 0001813403
Bryan K Segedi
Files at EXC (EXELON CORP), WAL (WESTERN ALLIANCE BANCORPORATION). First filing Nov 15, 2024, latest Nov 15, 2024.
In brief
Bryan K Segedi files SEC Form 4 as director at WAL (WESTERN ALLIANCE BANCORPORATION), and also at EXC (EXELON CORP). Since Nov 15, 2024, Bryan K Segedi has reported 0 open-market buys worth $0 and 1 open-market sell worth $94k, the latest filed on Nov 15, 2024.
A track record needs three past buys with six months of prices behind them; Bryan K Segedi has 0, so none is measured yet.
The newest scored trade: sold $94k of WAL on Nov 13, 2024, filed Nov 15, 2024, scored 25 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WAL: WESTERN ALLIANCE BANCORPORATION
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | WALsell WESTERN ALLIANCE BANCORPORATION | $94k 1,000 shares | -6% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 13, 2024 | WAL WESTERN ALLIANCE BANCORPORATION | 1,000 0.00% of outstanding | $95k | Nov 13, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | EXC EXELON CORP | AGrant or award 2026 Directors Restricted Stock Unitsderivative | +3,720 | $0.00 | $0 | 3,720 | Apr 29, 2026 |
| Mar 31, 2026 | EXC EXELON CORP | AGrant or award Common stock- deferred stock unitsindirect: By Exelon Corp. Directors Deferred Stock Unit Plan | +878 | $49.82 | $44k | 9,451 | Apr 1, 2026 |
| Feb 5, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | AGrant or award Deferred Stock Unitsderivative | +2,580 | $0.00 | $0 | 2,580 | Feb 9, 2026 |
| Dec 31, 2025 | EXC EXELON CORP | AGrant or award Common stock- deferred stock unitsindirect: By Exelon Corp. Directors Deferred Stock Unit Plan | +940 | $43.87 | $41k | 8,501 | Jan 2, 2026 |
| Sep 30, 2025 | EXC EXELON CORP | AGrant or award Common stock- deferred stock unitsindirect: By Exelon Corp. Directors Deferred Stock Unit Plan | +950 | $43.43 | $41k | 7,492 | Oct 1, 2025 |
| Jun 30, 2025 | EXC EXELON CORP | AGrant or award Common stock- deferred stock unitsindirect: By Exelon Corp. Directors Deferred Stock Unit Plan | +954 | $43.25 | $41k | 6,483 | Jul 2, 2025 |
| Mar 31, 2025 | EXC EXELON CORP | AGrant or award Common stock- deferred stock unitsindirect: By Exelon Directors Deferred Stock Unit Plan | +933 | $44.19 | $41k | 5,478 | Apr 2, 2025 |
| Dec 31, 2024 | EXC EXELON CORP | AGrant or award Common stock- deferred stock unitsindirect: By Exelon Directors Deferred Stock Unit Plan | +1,119 | $36.87 | $41k | 4,504 | Jan 3, 2025 |
| Nov 13, 2024 | WAL WESTERN ALLIANCE BANCORPORATION | SOpen-market sale Common Stock | -1,000 | $94.36 | $94k | 16,675 | Nov 15, 2024 |
Questions about Bryan K Segedi
Answered from the filings on this page, as of the latest one.
Is Bryan K Segedi buying or selling?
Not in the last 12 months. Bryan K Segedi's latest open-market trade on SEC Form 4 was sold $94k of WAL on Nov 13, 2024.
How did Bryan K Segedi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bryan K Segedi has 0.
Where does Bryan K Segedi file Form 4?
Bryan K Segedi has filed Form 4 at WAL (WESTERN ALLIANCE BANCORPORATION); EXC (EXELON CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.